QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

Q: What does CUSIP 74754R103 represent in this 13F holders report?

CUSIP 74754R103 is the security identifier for QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q3 2020?

15 institutional investors reported QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q3 2020. Use the holders table for investor-level position and value details.

CUSIP: 74754R103

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 6,138,804
Total 13F shares: 810,100
Share change: +699,243
Total reported value: $4,010,792
Price per share: $4.95
Number of holders: 15
Value change: +$3,531,748
Number of buys: 13
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020
Previous quarter: Q2 2020

Recent filing periods for CUSIP 74754R103:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

Top shareholders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
CITADEL ADVISORS LLC	13F	Company	0.55%	34,003	$135,000	—	30 Jun 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.49%	29,998	$119,000	—	30 Jun 2020	13F
Virtu Financial LLC	13F	Company	0.49%	29,887	$119,000	—	30 Jun 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.18%	10,783	$43,000	—	30 Jun 2020	13F
MORGAN STANLEY	13F	Company	0.08%	4,943	$20,000	—	30 Jun 2020	13F
BlackRock Finance, Inc.	13F	Company	0.01%	578	$2,000	—	30 Jun 2020	13F
UBS Group AG	13F	Company	0.01%	505	$2,000	—	30 Jun 2020	13F
Archer Investment Corp	13F	Company	0%	160	$635	—	30 Jun 2020	13F

Institutional Holders of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) as of Q3 2020

As of 30 Sep 2020, QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 810,100 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC, Cetera Investment Advisers, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, JPMORGAN CHASE & CO, MORGAN STANLEY, and Retirement Group, LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

Q3 2020 holders

Holder diff

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.